Fig. 3From: Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltratesROC curve analysis of VDAC expression in A BC, B ER (-), C ER (+), D PR (-), E PR (+), F HER2 (-), and G HER2 (+) BC group to discriminate from the normal groupBack to article page